Smart anticancer nanofibers: Setting treatments to work together

Jul 16, 2013
Smart anticancer nanofibers: Setting treatments to work together
Design concept for a smart hyperthermia nanofiber system that uses magnetic nanoparticles (MNPs) dispersed in temperature-responsive polymers. Anticancer drug, doxorubicin (DOX), is also incorporated into the nanofibers. The nanofibers are chemically crosslinked. First, the device signal (alternating magnetic field, AMF) is turned 'on' to activate the MNPs in the nanofibers. Then, the MNPs generate heat to collapse the polymer networks in the nanofiber, allowing the 'on-off' release of DOX. Both the generated heat and released DOX induce apoptosis of cancer cells by hyperthermic and chemotherapeutic effects, respectively.

Japanese researchers report that incorporating magnetic nanoparticles and an anticancer drug into crosslinked polymer nanofibers presents a twofold treatment for fighting cancer with diminished side effects.

Stimuli-responsive or 'smart' polymeric nanofibers have attracted increasing attention. The nanoscale structures give rise to high sensitivity to stimuli while they can also be manipulated easily as macroscopic materials. Now researchers at the University of Tsukuba and the National Institute of Materials Science in Japan have demonstrated how they can be used to host to exploit hyperthermal effects for treating cancer while avoiding the usual side-effects. The incorporation of doxorubicin in the nanofibers as well allows controlled release of the anticancer drug as an additional mechanism for killing cancer cells.

Magnetic nanoparticles can kill cancer cells through the heat generated by induction when subjected to an alternating magnetic field. Such hyperthermal treatments have also been shown to improve the efficacy of . However the nanoparticles can also lead to impaired , inflammation, and DNA damage. Incorporating the nanoparticles into nanofibers may provide a solution.

Young-Jin Kim , Mitsuhiro Ebara , and Takao Aoyagi electrspun the fibers from a solution of the polymer poly(NIPAAm- co -HMAAm) mixed with a solution of magnetic nanoparticles and doxorubicin. The heating caused by the nanoparticles when switching on an alternating magnetic field caused hyperthermal effects, as well as reversible deswelling and deformation of the fibers, which released the . Investigations in vitro and in cell lines demonstrated effective killing of cancer cells, which was greatly reduced for hyperthermal treatments alone in the absence of doxorubicin.

"The doxorubicin/magnetic-nanoparticles nanofi ber induced the apoptosis of due to a synergistic effect of chemotherapy and hyperthermia," say the authors. The work demonstrates how smart nanofibers have potential for use as a manipulative material that combines hyperthermia and drug release treatments that can be controlled with the simple switching on or off of an alternating magnetic field.

Explore further: Experts cautious over Google nanoparticle project

More information: A smart hyperthermia nanofi ber with switchable drug release for inducing cancer apoptosis Young-Jin Kim, Mitsuhiro Ebara, and Takao Aoyagi *,2013 Adv. Funct. Mater. doi: 10.1002/adfm.201300746

Provided by International Center for Materials Nanoarchitectonics (MANA)

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Nanoparticles for controlled drug release

Jun 13, 2013

Scientists from CIC bioGUNE and the Laboratoire de Chimie des Polymères Organiques (LCPO) in Bordeaux have jointly undertaken a project to develop "smart" nanoparticles. These polymeric particles act as "nanomissiles" against ...

Overcoming cancer drug resistance with nanoparticles

Jan 20, 2012

One of the ways in which cancer cells evade anticancer therapy is by producing a protein that pumps drugs out of the cell before these compounds can exert their cell-killing effects. A research team at Northwestern University ...

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.